MediWound (MDWD) Capital Expenditures (2013 - 2026)
MediWound (MDWD) posted quarterly Capital Expenditures of $8.6 million for Q4 2025, down 27.1% year-over-year from $11.7 million in Q4 2024, and up 918.95% quarter-over-quarter from -$1.0 million in Q3 2025.
MediWound (MDWD) Capital Expenditures (2013 - 2026) Analysis & Trends
MediWound's Capital Expenditures history runs 13 years deep, the most recent figure standing at $8.6 million for Q4 2025.
- In Q4 2025, Capital Expenditures fell 27.1% year-over-year to $8.6 million; the TTM figure through Dec 2025 stood at $5.5 million (down 12.24% YoY), while the FY2025 annual figure was $5.5 million, down 12.24% from the prior year.
- Capital Expenditures for Q4 2025 stood at $8.6 million, up from -$1.0 million in the prior quarter.
- The five-year high for Capital Expenditures was $11.7 million in Q4 2024, with the low at -$3.0 million in Q2 2024.
- The 5-year median for Capital Expenditures is -$959000.0 (2025), against an average of $1.0 million.
- The sharpest annual moves came in 2021 and 2023: Capital Expenditures jumped 74.0% in 2021, then plunged 840.62% in 2023.
- MediWound's Capital Expenditures stood at -$116000.0 in 2021, then slipped by 18.97% to -$138000.0 in 2022, then surged by 7867.39% to $10.7 million in 2023, then climbed by 9.53% to $11.7 million in 2024, then decreased by 27.1% to $8.6 million in 2025.
- Business Quant data shows MDWD's Capital Expenditures at $8.6 million in Q4 2025, -$1.0 million in Q3 2025, and -$1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 251.02 Mn |
| 10 | MediWound | 170.58 Mn | 139.58 Mn | 337,000.00 | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Jun 30, 2026 | 1.07 Mn |
| Dec 31, 2025 | 8.56 Mn |
| Dec 31, 2025 | 8.56 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Mar 31, 2025 | -959,000.00 |
| Mar 31, 2025 | -959,000.00 |
| Dec 31, 2024 | 11.74 Mn |
| Dec 31, 2024 | 11.74 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Mar 31, 2024 | -1.26 Mn |
| Mar 31, 2024 | -1.26 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Dec 31, 2023 | 10.72 Mn |